MSCC has a growing number of ethics approved clinical trials, including two randomised control trials for knee osteoarthritis and patient funded case series in osteoarthritis of the knee, hip, shoulder and other small joints. Both our early and 12 month data is showing improvements in pain and function. Our 12 month patient MRI’s will soon show if treatments have been able to regenerate what appears to be cartilage. Our treatment focus is now on; Improving pain and function, slowing degeneration and progression to joint replacement and regenerating what appears to be cartilage. Our pricing structure allows us to deliver treatments in line with new research
Our Treatment Options
High Dose Stem Cells
The objective of high dose stem cells are to not only improve pain and functional improvement but potentially regenerate cartilage. The same procedure is used with the low dose stem cells but an increased number of stem cells are injected. We hope to prove in our current trials that stem cell treatment will not only improve pain and function but regenerate cartilage too.
(Jo et al 2013, Wong et al 2014, Saw et al 2014)
MSCC offers a combination of both platelet rich plasma (PRP) and autologous conditioned serum (ACS) injections. Studies have shown significant reduction in pain within 5 weeks post injection and continued improvement in symptoms for up to 1+ years. Treatment involves 4-6 injections over weekly intervals with blood to be taken prior to the procedure.
(Rihbo et al, AJSM 2015)